#148 - Psychedelics for Mental Health

Matt delves into how psychedelics like psilocybin and LSD quiet the "Default Mode Network" to boost neuroplasticity. He describes these molecules as a "crowbar" that allows therapy to break deep-seated patterns of depression and reorganize the mind. Matt also reviews MDMA and ketamine trials for PTSD and trauma. While noting the brain's capacity for rapid change, he addresses research risks like the "blinding problem" and debunks microdosing myths. In essence, today’s episode presents a balan...